Real-World Impact of Pharmacogenomics and Comprehensive Medication Management Case Study

Answering the call for real-world data on the clinical and economic outcomes of pharmacogenomics (PGx) and comprehensive medication management (CMM), Coriell Life Sciences (CLS) – an international leader in precision medicine – has released new research on the impact of these tools at scale.

Molecular Diagnosis of Vaginitis: Comparing Quantitative PCR and Microbiome Profiling Approaches to Current Microscopy Scoring

Largest comprehensive study on diagnostic methods for infectious vaginitis.

Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry

PGx as an enhancement to the current standard of care for psychiatric patients.

Diagnosing Bacterial Vaginosis with a Novel, Clinically-Actionable Molecular Diagnostic Tool

White paper published July 18, 2018.

Pharmacogenetic guidelines and decision support tools for depression treatment:

LLD PGx evidence base incorporated into existing commercial decision support tools and clinical pharmacogenetic guidelines.